scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48.
Scpharmaceuticals Inc. (SCPH)
Market is closed
News
- 1 - 10
- Next >>
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript
PJ Kelleher: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded.
Is SCPH A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Hedge Funds Warming Up To scPharmaceuticals Inc. (SCPH)
In this article we will take a look at whether hedge funds think scPharmaceuticals Inc. (NASDAQ:SCPH) is a good investment right now.
Here is What Hedge Funds Think About scPharmaceuticals Inc. (SCPH)
Does scPharmaceuticals Inc. (NASDAQ:SCPH) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company.
13G Filing: RA Capital Management and Scpharmaceuticals Inc (SCPH)
Scpharmaceuticals Inc (NASDAQ:SCPH): Peter Kolchinsky's RA Capital Management filed an amended 13D.
You can check out RA Capital Management's latest holdings and filings here.
- 1 - 10
- Next >>
Billionaire Hedge Funds
